Article (Published version) (521 Kb) - 
Limited access to UNIGE
Highlights
More informations
Scientific Article
unige:77657 
 |
[Renal disease in ANCA-associated vasculitis] |
|
| Authors | ||
| Published in | Revue médicale suisse. 2014, vol. 10, no. 419, p. 493-497 | |
| Abstract | ANCA-associated vasculitis are systemic disorders characterized by inflammation predominantly involving small vessels. They are the most frequent cause of rapidly progressive glomerulonephritis in the elderly. They originate from complex interactions between genes and environment, resulting in autoimmunity and the generation of antibodies directed against neutrophil cytoplasmic antigens (ANCA), which may have pathogenic potential. Immunosuppressant agents, particularly cyclophosphamide, have considerably improved the prognosis, but infectious complications and relapses remain frequent. Recently, rituximab has been shown to be a good alternative to cyclophosphamide to induce remission. Additional knowledge should result in better clinical outcomes, minimizing side effects. | |
| Keywords | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/classification/complications/therapy — Antibodies, Monoclonal, Murine-Derived/therapeutic use — Humans — Kidney Diseases/etiology/therapy — Secondary Prevention — Severity of Illness Index | |
| Identifiers | PMID: 24665659 | |
| Full text | ||
| Structures | ||
| Research group | La matrice extracellulaire (651) | |
| Citation (ISO format) | FUMEAUX, David et al. [Renal disease in ANCA-associated vasculitis]. In: Revue médicale suisse, 2014, vol. 10, n° 419, p. 493-497. https://archive-ouverte.unige.ch/unige:77657 |
114 hits 
0 download 
Contact an author
Update